ABX · Abacus Global Management, Inc.

Track ABX — free

$9.74 -0.09 (-0.92%) At close · Aug 28

Russell 2000 member Rebalance outlook locked

Market Cap

$952.50M

97.79M

Up next

Next earnings call

Nov 5, 2026 Est · unconfirmed · in 10 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 10, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Research

our published analysis of this company

Buybacks Roundup August 17, 2026

Trimble's $1B Authorization Lifts Week's Buyback Total to $1.3B; Six Other Programs Trail by an Order of Magnitude

Seven companies authorized a combined $1.3 billion in share repurchases between August 10 and August 16, with Trimble Inc.'s $1 billion program accounting for 76.9% of the weekly total and running ten times the size of the next-largest authorization.

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Weak Sentiment Bullish Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 14.4 · calm Equity put/call 0.62

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +9%

above

Price vs 50-day avg −4%

below

RSI (14) 50

neutral

MACD trend Positive

52-week position 68%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Weak

1-month return −6%

trailing

6-month return +1%

trailing

YTD return +14%

this year

Relative strength −12%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $10 › 200d $9 — 50d above 200d

Institutional flow Accumulating

+14% holders QoQ · +40 funds added

Insider flow Distributing

Net -$4.0M over 90 days · 100% sells

Short interest Falling

5.56% of float · ▼ -2.3% MoM · 7.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

150 holders — near 3-yr high, broad support

Squeeze score 70

elevated · 0–100

Fundamentals

Fair

Revenue growth +110%

Y/Y

Gross margin 88%

contracting

EPS growth +206%

Y/Y

Free cash flow $-26.6M

Valuation P/E 36.1

rich

Buyback $100.0M

authorized

Balance sheet $367.7M

net debt

Quant / Vol

risk profile

Very High

Volatility 57%

annualized · 1-yr

Max drawdown −30%

past year

ATR 4.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 6, 2026

Adjusted net income (Gross) · FY26 Non-GAAP Initiated $100M – $106M

Prior guidance period ended · from the Earnings Call filed Mar 31, 2026

Adjusted net income · Q2 2026 $24M – $26M

Adjusted EPS · Q2 2026 $0.24 – $0.26

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

0 · 5 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+9% Bullish

Price vs 50-day avg

−4% Neutral

RSI (14)

50 Neutral

MACD trend

Positive Bullish

52-week position

68% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $10 › 200d $9 — 50d above 200d

Institutional flow Accumulating

+14% holders QoQ · +40 funds added

Insider flow Distributing

Net -$4.0M over 90 days · 100% sells

Short interest Falling

5.56% of float · ▼ -2.3% MoM · 7.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

150 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $5 Now $10 · 68% Range high $12

vs 200-day avg +9% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
ADJUSTED EPS - BASIC non-GAAP	$0.23	the three months ended June 30, 2026 filing	+4.5%

ADJUSTED EPS - DILUTED non-GAAP	$0.23	the three months ended June 30, 2026 filing	+9.5%

Average management fee on ETF Funds	0.45%	Three Months Ended June 30, 2026 filing	—
Average management fee on Longevity Funds	1.05%	Three Months Ended June 30, 2026 filing	—
Capital outflows	-$49,262,235	the three months ended June 30, 2026 filing	—
Holding period on existing policies (in days)	153	Three Months Ended June 30, 2026 filing	—
Holding period on sold policies (in days)	230	Three Months Ended June 30, 2026 filing	—
Number of external counter parties that purchased policies	6	Three Months Ended June 30, 2026 filing	-60.0%

Number of policy originations to subsidiaries eliminated in consolidation	138	Three Months Ended June 30, 2026 filing	—
Policies bought	288	Three Months Ended June 30, 2026 filing	+15.2%

Policies bought from related parties	8	Three Months Ended June 30, 2026 filing	-61.9%

Policies matured	19	Three Months Ended June 30, 2026 filing	+280.0%

Policies originated for external investors	44	Three Months Ended June 30, 2026 filing	+51.7%

Policies sold	399	Three Months Ended June 30, 2025 filing	—
Policies sold to related parties	354	Three Months Ended June 30, 2025 filing	—
Total lifetime realized gains from maturities, net of lifetime premiums paid	$19,268,981	Three Months Ended June 30, 2026 filing	+439.2%

Total lifetime realized gains, net of lifetime premiums paid	$58,332,682	Three Months Ended June 30, 2025 filing	—
Turnover ratio	2	Three Months Ended June 30, 2026 filing	—
Weighted average realized gain on policies sold	26.3%	Three Months Ended June 30, 2025 filing	—
Adjusted Annualized ROE non-GAAP	22%	Six Months Ended June 30, 2026	—

Adjusted Annualized ROIC non-GAAP	20%	Six Months Ended June 30, 2026	—

Adjusted EBITDA non-GAAP	$72,596,972	Six Months Ended June 30, 2026	—

Adjusted EBITDA Margin non-GAAP	54.8%	Six Months Ended June 30, 2026	—

Adjusted EPS (Gross) non-GAAP	$0.28	2Q26	—
Adjusted Net Income non-GAAP	$39,497,137	Six Months Ended June 30, 2026	—

Adjusted net income (Gross) non-GAAP	27.1M	2Q26	—
Annualized ROE non-GAAP	25%	2Q26	—

Annualized ROIC non-GAAP	23%	2Q26	—

Average realized gain	25%	2Q26	—

Capital inflows	256.1M	2Q26	—
Longevity funds new capital raised	544.2M	First-Half 2026	—
Adjusted - Diluted non-GAAP	$0.17	Three Months Ended March 31, 2026	—
Gross AUM	3.6B	Q1 2026	—
Gross capital inflows	378M	Q1 2026	—
Origination capital deployment	163.6M	Q1 2026	—

Policies held	659	Q1 2026	—
Number of policy originations	1,310	Full Year 2025	—
Originations capital deployment	580.8M	Full Year 2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Life — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ABX Abacus Global Management, Inc. this stock	$952.50M	+13.9%	+110.2%	36.1	5.6%
CILJF China Life Insurance Co Ltd	$105.43B	+8.7%	—	—	0.0%
MFC Manulife Financial Corp	$71.71B	+17.9%	—	—	1.3%
MET Metlife Inc	$61.16B	+22.3%	+8.6%	18.4	1.8%
AFL Aflac Inc	$58.42B	+5.7%	-9.3%	12.6	2.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

150

% held: 28.7%
Net QoQ: +679.3K sh
Top holder: ROYCE & ASSOCIATES LP

Held Float

View

Held by Funds

Fund positions

107

View

Short & Settlement

Short Interest Falling

Shares short

5.4M

Days to cover: 7.8d
Change: -130.6K sh

View

Short Volume

Short vol %

38%

As of: Aug 28, 2026

Short Total

View

Fails to Deliver

FTD shares

24.8K

Value: $259.6K
As of: Jul 31, 2026

View

Off-Exchange

Off-exchange %

41.9%

Week of: Jul 20, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$4.0M

Buyers / Sellers: 0 / 5

Buyers Sellers

View

Financials

Revenue (FY)

$235.2M

Net income (FY): $36.5M
EPS diluted: $0.36

View

Buybacks

Authorized

$100.0M

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 24, 2026
This year: 17

View

Proposed Sales

Value

$1.2M

Shares: 125.0K
Filed: Aug 19, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 6, 2026

View

Performance

	5D	20D	120D	MTD	YTD
ABX	+0.8%	-5.5%	+1.1%	-5.5%	+13.9%
SPY	+0.5%	+3.0%	+13.4%	+3.0%	+12.8%
vs SPY	+0.4%	-8.5%	-12.3%	-8.5%	+1.1%

Capital returns

Latest dividend

$0.20 / share · ex Dec 2, 2025

Paid (TTM)

$0.20 / share · 1 payout

Dividend yield (TTM, derived)

— · history filling in

Buyback program · as of Aug 13, 2026

Authorized

$100.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1814287 CUSIP 00258Y104 13F (30d) 127 filings 127 filers Visit website Investor relations

ABX · Abacus Global Management, Inc.

Price & Indicators

Up next

AI Brief

Equibles Research

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns